| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) financing activities | 108,151 | 7,634 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 470 | 492 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 178,544 | -13,961 |
| Cash and cash equivalents at beginning of period | 166,094 | - |
| Cash and cash equivalents at end of period | 344,638 | - |
NovoCure Ltd (NVCR)
NovoCure Ltd (NVCR)